How will 'Indian Ozempics' change treatment for diabetes and obesity?
With the patent for semaglutide expired in India, nearly 40 generic versions of Ozempic are now available or soon to be released. This episode of In Focus by The Hindu discusses how these more affordable GLP-1 drugs will affect diabetes and obesity treatment in India…